Important Safety Information

Wegovy (semaglutide) injection is a prescription medicine for patients with obesity or with overweight, who also have weight-related medical problems, to help them lose weight and maintain weight loss, paired with diet and exercise. Wegovy is also used to reduce the risk of major cardiovascular (CV) events in patients with known CV disease and obesity or overweight. Wegovy is semaglutide and should not be used with other semaglutide-containing products or other GLP-1s. Wegovy may cause serious side effects including possible thyroid tumors and thyroid cancer. Do not use Wegovy if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Wegovy may cause other serious side effects, including pancreatitis, gallbladder problems, increased risk of low blood sugar, kidney problems, serious allergic reactions, changes in vision in patients with type 2 diabetes, increased heart rate, and depression or suicidal thoughts. Tell your provider if you have a planned surgery. For more complete information, including Boxed Warning, visit ro.co/safety-info/glp1 .